What are the pathological findings of non-bullous pemphigoid and how does it differ from bullous pemphigoid?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathological Findings of Non-Bullous Pemphigoid and Differences from Bullous Pemphigoid

Non-bullous pemphigoid (NBP) is a distinct variant of bullous pemphigoid (BP) characterized by the absence of blisters but with identical immunopathological findings, including linear deposits of IgG and/or C3 along the dermoepidermal junction. 1, 2

Pathological Findings of Non-Bullous Pemphigoid

Histopathology

  • Light microscopy findings:
    • Moderate eosinophilic infiltrate partly arranged along the basement membrane zone 3
    • Eosinophils may focally invade the epidermis 3
    • Generally nonspecific findings compared to bullous form 2, 4
    • No subepidermal clefting (unlike bullous pemphigoid) 2
    • Dermal infiltrate of eosinophils and/or neutrophils 1

Immunopathology

  • Direct immunofluorescence (DIF):

    • Linear deposits of IgG and/or C3 along the dermoepidermal junction 1
    • Positive in approximately 93% of cases 4
    • Biopsy must be taken from perilesional skin (1 cm away from lesion) 1, 5
    • Sometimes IgA and IgE with similar pattern 1
  • Indirect immunofluorescence (IIF):

    • Positive in about 90% of cases 4
    • Best performed on salt-split skin 1
    • IgG autoantibodies bind to the epidermal side of the split 1
  • Immunoelectron microscopy:

    • Deposits localized within the lamina lucida and over hemidesmosomal plaques 3
  • Serological findings:

    • Circulating autoantibodies against BP230 (230 kD bullous pemphigoid antigen) 3
    • Anti-BP180 (collagen XVII) antibodies may be present 1, 5
    • Elevated IgE levels (4.1 times higher than in bullous form) 6
    • Significantly increased blood eosinophil count 6

Differences Between Non-Bullous and Bullous Pemphigoid

Clinical Presentation

  • Non-bullous pemphigoid:

    • No blisters or vesicles 3, 2
    • Presents with pruritic papules/nodules (37%) or pruritus without primary skin lesions (22%) 2
    • Erythematous, urticarial plaques (52.3%) 4
    • Excoriations, prurigo-like lesions, eczematous lesions 1, 5
    • May precede bullous form by weeks, months, or years 1
    • Only 9.8-23% of patients develop blisters during follow-up 2, 6
  • Bullous pemphigoid:

    • Tense blisters on erythematous or normal-looking skin 1
    • Widespread or localized bullae 1
    • Oral mucosal involvement in 10-30% of cases 1

Histopathology

  • Non-bullous pemphigoid:

    • No subepidermal clefting 2
    • Nonspecific findings in most cases 2, 4
  • Bullous pemphigoid:

    • Subepidermal clefting with inflammatory infiltrate 1
    • Dermal infiltrate predominantly of eosinophils 1

Diagnostic Challenges

  • Non-bullous pemphigoid:

    • Mean diagnostic delay of 22.6-29 months 2, 4
    • Mimics other pruritic skin diseases 4
    • Requires high index of suspicion in elderly patients with refractory pruritus 5
  • Bullous pemphigoid:

    • More readily diagnosed due to characteristic blisters 1

Laboratory Markers

  • Non-bullous pemphigoid:
    • Higher IgE levels 6
    • Higher blood eosinophil count 6
    • Positive IIF and BP180 immunoblot associated with higher risk of developing blisters 2

Clinical Implications

  • Both forms affect predominantly elderly patients (>70 years) 1, 5
  • Both have similar mortality rates (8.6-fold increased all-cause mortality risk in NBP) 2
  • Both respond to similar treatments, though treatment intensity may differ 5
  • Both are associated with neurological conditions such as dementia, Parkinson's disease, and cerebrovascular disease 5

Diagnostic Algorithm for Suspected Non-Bullous Pemphigoid

  1. Consider in elderly patients with persistent unexplained pruritus, especially with urticarial or eczematous lesions 5, 4
  2. Perform skin biopsy for histopathology (may show nonspecific findings) 2
  3. Obtain perilesional skin biopsy for DIF (essential for diagnosis) 1
  4. Perform serum testing with IIF on salt-split skin and ELISA for anti-BP180 and anti-BP230 antibodies 1, 5
  5. Monitor for potential development of blisters, especially in patients with positive IIF and BP180 immunoblot 2

Understanding these differences is crucial for early diagnosis and appropriate management of non-bullous pemphigoid, which is often underdiagnosed due to its atypical presentation.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?

Journal of the American Academy of Dermatology, 1993

Research

Nonbullous pemphigoid: A systematic review.

Journal of the American Academy of Dermatology, 2018

Guideline

Bullous Pemphigoid Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.